Pacific Biosciences of Ca... (PACB)
NASDAQ: PACB
· Real-Time Price · USD
1.30
0.07 (5.69%)
At close: Aug 15, 2025, 3:59 PM
1.30
-0.36%
After-hours: Aug 15, 2025, 04:35 PM EDT
Pacific Biosciences of California Balance Sheet Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Cash & Equivalents | 54.8M | 58.51M | 55.37M | 77.98M | 99.53M | 76.95M | 180.21M | 385.65M | 209.29M | 353.83M | 325.09M | 304.43M | 310.44M | 428.57M | 460.73M | 425.39M | 459.79M | 932.4M |
Short-Term Investments | 259.93M | 284.6M | 334.56M | 393.17M | 410.28M | 485.27M | 451.5M | 382.14M | 620.58M | 521.06M | 447.23M | 529.91M | 588.71M | 534.2M | 583.67M | 654.5M | 684.58M | 227.92M |
Long-Term Investments | 1.53M | n/a | n/a | n/a | 1.92M | 2.42M | 2.42M | n/a | n/a | 2.92M | 2.92M | 2.92M | 2.92M | 4.98M | 4.59M | 4.56M | 3M | 3.5M |
Other Long-Term Assets | 9.01M | 10.72M | 10.84M | 11.04M | 9.79M | 10.12M | 13.27M | 15.43M | 13.14M | 13.32M | 10.53M | 1.18M | -1.72M | -3.64M | -3.42M | -4.49M | -2.94M | -3.43M |
Receivables | 32.26M | 31.64M | 27.52M | 29.38M | 32.43M | 30.32M | 36.62M | 30.49M | 24.03M | 29.59M | 18.79M | 22.76M | 27.06M | 27.85M | 24.24M | 23.95M | 19.94M | 12.91M |
Inventory | 53.84M | 54.01M | 58.76M | 65.74M | 68.59M | 67.34M | 56.68M | 68.26M | 67.61M | 61.95M | 50.38M | 43.49M | 36.12M | 29.63M | 24.6M | 18.28M | 17.98M | 16.27M |
Other Current Assets | 12.57M | 16.16M | 19.47M | 17.97M | 342K | n/a | 3M | 300K | 300K | 300K | 300K | 900K | 900K | 1.1M | 500K | 1.2M | 1M | 1.54M |
Total Current Assets | 413.4M | 444.92M | 495.68M | 584.23M | 628.14M | 677.02M | 742.05M | 882.3M | 935.55M | 984.03M | 855M | 916.82M | 973.21M | 1.03B | 1.11B | 1.13B | 1.19B | 1.2B |
Property-Plant & Equipment | 66.61M | 69.2M | 46.6M | 49.3M | 57.3M | 67.96M | 69.03M | 74.95M | 76.76M | 79.08M | 81.34M | 80.69M | 81.23M | 80.43M | 79.12M | 76.98M | 53.58M | 53.37M |
Goodwill & Intangibles | 334.92M | 335.94M | 707.33M | 805.49M | 812.34M | 912.39M | 919.25M | 925.68M | 819.75M | 819.99M | 820.22M | 820.27M | 820.5M | 820.73M | 820.95M | 822.74M | n/a | n/a |
Total Long-Term Assets | 412.07M | 415.87M | 764.77M | 865.82M | 881.35M | 992.9M | 1B | 1.02B | 912.08M | 912.38M | 912.09M | 902.13M | 902.93M | 902.5M | 901.24M | 899.79M | 53.65M | 53.44M |
Total Assets | 825.47M | 860.79M | 1.26B | 1.45B | 1.51B | 1.67B | 1.75B | 1.9B | 1.85B | 1.9B | 1.77B | 1.82B | 1.88B | 1.94B | 2.01B | 2.03B | 1.25B | 1.25B |
Account Payables | 15.05M | 14.04M | 16.59M | 12.06M | 17.49M | 21.01M | 15.06M | 16.11M | 16.51M | 17.39M | 12.03M | 12.85M | 12.88M | 17.61M | 11M | 4.96M | 4.76M | 3.47M |
Deferred Revenue | 14.86M | 15.24M | 13.86M | 17.29M | 19.21M | 17.35M | 16.34M | 22.37M | 24.98M | 32.72M | 32.29M | 32.45M | 33.91M | 37.98M | 36.03M | 28.22M | 19.69M | 15.29M |
Short-Term Debt | 703K | 2.42M | 10.03M | 10.68M | 12.49M | 152K | 490K | 444K | n/a | -196.19M | 10.73M | 8.61M | 8.35M | n/a | 1.61M | 7.13M | 4.64M | 4.45M |
Other Current Liabilities | 28.43M | 3.15M | 4.09M | -9.89M | -5.74M | 2.68M | 7.84M | 100.92M | 193.66M | -7.17M | -17.82M | -4M | -2.44M | 3.13M | 4.15M | -4.2M | -1.06M | -2.91M |
Total Current Liabilities | 59.75M | 66.6M | 66.3M | 60M | 78.39M | 72.95M | 95.03M | 183.96M | 271.41M | 69.48M | 76.92M | 70.19M | 71.97M | 75.07M | 83.29M | 64M | 47.36M | 33.44M |
Long-Term Debt | 646.44M | 646.21M | 647.49M | 893.14M | 892.84M | 892.54M | 892.24M | 892M | 891.79M | 896.84M | 897.18M | 896.53M | 896.37M | 896.22M | 898.37M | 895.91M | 895.76M | 895.67M |
Other Long-Term Liabilities | n/a | n/a | 19.25M | 21.4M | 20.23M | 20.23M | 20.3M | 19.5M | 837K | 969K | 800K | 169.25M | 166.16M | 171.87M | 170.89M | 173.42M | 752K | 752K |
Total Long-Term Liabilities | 704.23M | 702.55M | 687.55M | 936.93M | 938.4M | 947.95M | 949.68M | 950.65M | 934.22M | 1.13B | 1.13B | 1.12B | 1.12B | 1.13B | 1.13B | 1.13B | 940.18M | 938.9M |
Total Liabilities | 763.98M | 769.15M | 753.85M | 996.93M | 1.02B | 1.02B | 1.04B | 1.13B | 1.21B | 1.2B | 1.2B | 1.19B | 1.19B | 1.2B | 1.22B | 1.19B | 987.54M | 972.34M |
Total Debt | 699.22M | 699.11M | 672.43M | 920.75M | 924.95M | 931.37M | 933.93M | 935.56M | 937.64M | 944.83M | 957.37M | 948.3M | 950.22M | 952.02M | 953.75M | 953M | 935.84M | 936.61M |
Common Stock | 300K | 300K | 294K | 274K | 272K | 272K | 268K | 258K | 250K | 250K | 227K | 226K | 225K | 224K | 221K | 221K | 199K | 198K |
Retained Earnings | -2.62B | -2.58B | -2.15B | -2.15B | -2.09B | -1.92B | -1.84B | -1.76B | -1.69B | -1.62B | -1.53B | -1.45B | -1.37B | -1.3B | -1.22B | -1.15B | -1.17B | -1.12B |
Comprehensive Income | 267K | 381K | 422K | 1.55M | -523K | -306K | 219K | -1.84M | -2.69M | -1.92M | -4.76M | -6.26M | -5.46M | -4.08M | -1.09M | 27K | -6K | 74K |
Shareholders Equity | 61.49M | 91.64M | 506.59M | 453.12M | 492.7M | 649.02M | 701.3M | 763.74M | 642M | 692.12M | 562.9M | 626.59M | 681.89M | 734.58M | 790.99M | 840.81M | 258.25M | 280.55M |
Total Investments | 261.46M | 284.6M | 334.56M | 393.17M | 410.28M | 487.69M | 453.93M | 382.14M | 620.58M | 521.06M | 447.23M | 529.91M | 588.71M | 534.2M | 583.67M | 654.5M | 684.58M | 227.92M |